LQZ-7I is a survivin-targeting inhibitor. LQZ-7I inhibits survivin dimerization. LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors[1].
Molecular Weight:
348.35
Purity:
99.88
CAS Number:
[195822-23-2]
Formula:
C20H14F2N4
Target:
Survivin
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted